Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | G6PD | P11413 | 11/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 4/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 2/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 2/20 | 1.00 |
| ▸ | PMP22 | Q01453 | 2/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 2/20 | 1.00 |
| ▸ | TSHR | P16473 | 1/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 1.00 |
| ▸ | MAPT | P10636 | 1/20 | 1.00 |
| ▸ | GABRP | O00591 | 2/20 | 0.74 |
| ▸ | GABRD | O14764 | 2/20 | 0.74 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.74 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.74 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.74 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.74 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.74 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.74 |
| ▸ | GABRA2 | P47869 | 2/20 | 0.74 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.74 |
| ▸ | GABRA4 | P48169 | 2/20 | 0.74 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19229447 | 1.00 | G6PD (1.00) | G6PDCYP3A4CYP1A2CYP2C9PMP22 | |
| SCHEMBL20781183 | 1.00 | G6PD (1.00) | G6PDCYP3A4CYP1A2CYP2C9PMP22 | |
| SCHEMBL642973 | 1.00 | G6PD (1.00) | G6PDCYP3A4CYP1A2CYP2C9PMP22 | |
| SCHEMBL5496387 | 1.00 | G6PD (1.00) | G6PDCYP3A4CYP1A2CYP2C9PMP22 | |
| SCHEMBL21645690 | 1.00 | G6PD (1.00) | G6PDCYP3A4CYP1A2CYP2C9PMP22 | |
| SCHEMBL22593890 | 1.00 | G6PD (1.00) | G6PDCYP3A4CYP1A2CYP2C9PMP22 | |
| SCHEMBL17776488 | 1.00 | G6PD (1.00) | G6PDCYP3A4CYP1A2CYP2C9PMP22 | |
| SCHEMBL4557082 | 1.00 | G6PD (1.00) | G6PDCYP3A4CYP1A2CYP2C9PMP22 | |
| SCHEMBL18373713 | 1.00 | G6PD (1.00) | G6PDCYP3A4CYP1A2CYP2C9PMP22 | |
| SCHEMBL10381095 | 1.00 | G6PD (1.00) | G6PDCYP3A4CYP1A2CYP2C9PMP22 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 298 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260148848-A1 | BIOMARKERS FOR DIAGNOSIS AND TREATMENT OF ENDOCRINE HYPERTENSION, AND METHODS OF IDENTIFICATION THEREOF | INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (FR) | 2026-05-28 | — | — | US | claimed |
| US-12426782-B2 | Systems and temporal alignment methods for evaluation of gestational age and time to delivery | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2025-09-30 | — | — | US | claimed |
| EP-4562182-A1 | BIOMARKERS FOR DIAGNOSIS AND TREATMENT OF ENDOCRINE HYPERTENSION, AND METHODS OF IDENTIFICATION THEREOF | INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (FR) | 2025-06-04 | — | — | EP | claimed |
| CN-113396332-B | Method for evaluating pregnancy progression and premature abortion for clinical intervention and use thereof | 斯坦福大学托管董事会 | 2025-02-11 | — | — | CN | claimed |
| WO-2025024501-A1 | NEUROMODULATORY PEPTIDES | LACTOCORE, INC. (US) | 2025-01-30 | — | — | WO | claimed |
| CN-119306780-A | Lipid prodrugs of pregnane neurosteroids and uses thereof | 海港治疗公司 | 2025-01-14 | — | — | CN | claimed |
| US-20240358719-A1 | Formulations for Prolonging Gestation and for Complications of Menstruation or Gestation | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2024-10-31 | — | — | US | claimed |
| US-20240047065-A1 | BIOMARKERS FOR DIAGNOSIS AND TREATMENT OF ENDOCRINE HYPERTENSION, AND METHODS OF IDENTIFICATION THEREOF | UNIVERSITY OF DUNDEE (GB) | 2024-02-08 | — | — | US | claimed |
| EP-4313061-A1 | FORMULATIONS FOR PROLONGING GESTATION AND FOR COMPLICATIONS OF MENSTRUATION OR GESTATION | The Board of Trustees of the Leland Stanford Junior University (US) | 2024-02-07 | — | — | EP | claimed |
| EP-4292102-A1 | BIOMARKERS FOR DIAGNOSIS AND TREATMENT OF ENDOCRINE HYPERTENSION, AND METHODS OF IDENTIFICATION THEREOF | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE - INSERM (FR) | 2023-12-20 | — | — | EP | claimed |
| US-5591733-A | TREATMENT OF ANXIETY, STRESS, INSOMNIA, SEIZURES, STEROIDS, ACTIVE AT GAMMA-AMINOBUTYRIC ACID RECEPTORS | UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 1997-01-07 | — | — | US | claimed |
| EP-0701444-A1 | METHODS AND COMPOSITIONS FOR INDUCING SLEEP | COCENSYS, INC. (US) | 1996-03-20 | — | — | EP | claimed |
| EP-0659072-A1 | PHARMACEUTICAL EMULSIONS CONTAINING BIOACTIVE STEROIDS | Pharmacia AB (SE) | 1995-06-28 | — | — | EP | claimed |
| WO-1995001162-A1 | PHARMACEUTICAL EMULSIONS CONTAINING BIOACTIVE STEROIDS | PHARMACIA AB (SE) | 1995-01-12 | — | — | WO | claimed |
| WO-1994027608-A9 | METHODS AND COMPOSITIONS FOR INDUCING SLEEP | — | 1995-01-12 | — | — | WO | claimed |
| WO-1994027608-A1 | METHODS AND COMPOSITIONS FOR INDUCING SLEEP | COCENSYS, INC. (US) | 1994-12-08 | — | — | WO | claimed |
| EP-0554436-A4 | — | — | 1994-01-12 | — | — | EP | claimed |
| EP-0554436-A1 | GABA RECEPTOR MODULATORS | COCENSYS, INC. (US) | 1993-08-11 | — | — | EP | claimed |
| US-5232917-A | Tranquillizers; antianxiolytic agents; sedatives; antidepressants; anticonvulsants; neurotransmitters | UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 1993-08-03 | — | — | US | claimed |
| WO-1993003732-A1 | GABA RECEPTOR MODULATORS | COCENSYS, INC. (US) | 1993-03-04 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240358719-A1 | Formulations for Prolonging Gestation and for Complications of Menstruation or Gestation | PGF, GNRHR, PTGDR | G6PD 695/4885CYP3A4 647/4885CYP1A2 329/4885 |
| US-20260148848-A1 | BIOMARKERS FOR DIAGNOSIS AND TREATMENT OF ENDOCRINE HYPERTENSION, AND METHODS OF IDENTIFICATION THEREOF | SHBG, HSD11B2, HSD11B1 | G6PD 1366/4885CYP3A4 3050/4885CYP1A2 2344/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.